Europe Skin Cancer Diagnostics Market Forecast 2023-2032

Europe Skin Cancer Diagnostics Market Forecast 2023-2032

KEY FINDINGS

The Europe skin cancer diagnostics market is projected to register a CAGR of 6.72% during the forecast period, 2023-2032. The market growth is attributed to proactive measures, educational initiatives, and public health campaigns undertaken by individuals and healthcare providers.

MARKET INSIGHTS

Belgium, Poland, Italy, Nordic Countries, Germany, Spain, France, the United Kingdom, and Rest of Europe are assessed for the Europe skin cancer diagnostics market growth evaluation. In Italy, as per the Italian Cancer Society, new skin melanoma’s annual average stands at 12.5 per 100,000 males and 13. per 100,000 females. Also, as per the World Health Organization 2020 data, skin cancer deaths reached 3239 total deaths in the country. Further, the cost of anticancer drugs is on the rise. For instance, the treatment cost of advanced melanoma range around €2972 in Italy. In addition, the pharmaceutical expense for anticancer drugs increased from 3.6 to 5 billion euros between 2013-2017.

At the same time, as per stats, the public healthcare expenditure has increased steadily in the last two decades, exceeding 127 billion euros as of 2021. Similarly, private healthcare expenditure reached almost 4 billion euros in 2020. As a result, the rising costs of anticancer drugs in Italy reflect the growing demand for effective skin cancer treatment, including skin cancer diagnostics. This offers growth opportunities for the Italy skin cancer diagnostics market.

Whereas countries like Spain have a well-developed medical technology industry, which encompasses a vast range of diagnostic tools and devices. The Spain skin cancer diagnostics market growth is propelled by the growing aging population, increasing awareness about skin cancer risks, and advancements in diagnostic technology.

COMPETITIVE INSIGHTS

Some of the major companies operating in the market include F Hoffmann-La Roche Ltd, AMLo Biosciences Limited, NeraCare GmbH, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments